[HTML][HTML] Prolactin level changes according to atypical antipsychotics use: a study based on clinical data warehouse
S Kim, JH Jeong, YH Um, TW Kim, H Seo… - Clinical …, 2023 - ncbi.nlm.nih.gov
… the use of antipsychotic drugs in patients through the Clinical … Hyper-prolactinemia inhibits
the secretion of luteinizing hormone (… In an open-label study on prolactin elevation of atypical …
the secretion of luteinizing hormone (… In an open-label study on prolactin elevation of atypical …
Hyperprolactinaemia in the context of psychiatry
K Romain, S Fynes-Clinton, D Harmer… - BJPsych Advances, 2021 - cambridge.org
… hyperprolactinaemia and preferred units of measurement differ across … Comparatively, of
the second-generation antipsychotics the … to relieve troubling symptoms in patients prescribed …
the second-generation antipsychotics the … to relieve troubling symptoms in patients prescribed …
Antipsychotic medication for women with schizophrenia spectrum disorders
BA Brand, YRA Haveman, F De Beer… - Psychological …, 2022 - cambridge.org
… on the differences in the action of antipsychotic medication in … Sex, ethnicity, and antipsychotic
medication use in patients with … exposure to secondgeneration antipsychotics given with …
medication use in patients with … exposure to secondgeneration antipsychotics given with …
[HTML][HTML] … clinical effect of alpha-lipoic acid administration in schizophrenic subjects stabilized with atypical antipsychotics: A 12-week, open-label, uncontrolled study
F Iannuzzo, GA Basile, D Campolo, G Genovese… - Current Research in …, 2022 - Elsevier
… second generation antipsychotics can induce metabolic side … and dyslipidaemia in patients
treated with atypical antipsychotics … study, ALA significantly reduced prolactinaemia after 12 …
treated with atypical antipsychotics … study, ALA significantly reduced prolactinaemia after 12 …
[HTML][HTML] Lumateperone for the Treatment of Schizophrenia
A Edinoff, N Wu, C deBoisblanc… - Psychopharmacology …, 2020 - ncbi.nlm.nih.gov
… can cause myriad side effects, most prominently prolactinemia and extrapyramidal side …
symptoms and EPS in patients with schizophrenia. The year-long open-label study 303 was also …
symptoms and EPS in patients with schizophrenia. The year-long open-label study 303 was also …
Drug safety evaluation of aripiprazole in bipolar disorder
A Cuomo, B Beccarini Crescenzi… - Expert Opinion on …, 2019 - Taylor & Francis
… Hypo-prolactinemia may be related to sperm abnormalities … , especially in patients with risk
factors for TD such as female … A 46-week open-label extension study [Citation65] evaluated …
factors for TD such as female … A 46-week open-label extension study [Citation65] evaluated …
Pharmacological strategies for sexual recovery in men undergoing antipsychotic treatment
TB Jannini, A Sansone, R Rossi… - Expert Opinion on …, 2022 - Taylor & Francis
… onset of SD in patients undergoing antipsychotic treatments. … open-label study on MDD, the
Authors compared the effect of … results in high levels of prolactinemia, a peripheral marker of …
Authors compared the effect of … results in high levels of prolactinemia, a peripheral marker of …
[PDF][PDF] Hyperprolactinemia in psychiatric patients taking antipsychotic medications: A longitudinal study in a tertiary hospital in South-South, Nigeria
… Differences in the effect of second-generation antipsychotics on prolactinaemia: six
weeks open-label trial in female in-patients. Neuroendocrinol Lett. 2007;28(…
weeks open-label trial in female in-patients. Neuroendocrinol Lett. 2007;28(…
Major depressive disorder (MDD) and schizophrenia–Addressing unmet needs with partial agonists at the D2 receptor: A review
… , even in patients showing minimal response after 8 weeks of … The other study was an
open-label design in 1015 patients … or prolactinemia with other antipsychotic treatments. However, …
open-label design in 1015 patients … or prolactinemia with other antipsychotic treatments. However, …
Drug-induced gynecomastia: A systematic review and meta-analysis of randomized clinical trials
… with an open-label or single/double blinded design, which … antipsychotics and some
secondgeneration antipsychotics, … , our study confirmed the high risk of gynecomastia in patients …
secondgeneration antipsychotics, … , our study confirmed the high risk of gynecomastia in patients …